gabapentin
Generic: gabapentin
Labeler: ascend laboratories, llcDrug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
ascend laboratories, llc
Dosage Form
TABLET
Routes
Active Ingredients
gabapentin 800 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
67877-429
Product ID
67877-429_280c139f-c3a2-46e4-b990-ce3808166e86
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA206402
Listing Expiration
2026-12-31
Marketing Start
2015-11-01
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
67877429
Hyphenated Format
67877-429
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA206402 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 800 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (67877-429-01)
- 500 TABLET in 1 BOTTLE (67877-429-05)
- 1000 TABLET in 1 BOTTLE (67877-429-10)
- 100 BLISTER PACK in 1 CARTON (67877-429-38) / 10 TABLET in 1 BLISTER PACK
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "280c139f-c3a2-46e4-b990-ce3808166e86", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310433", "310434"], "spl_set_id": ["4d445d1d-02d1-4a59-b3b2-9ba5cd924c9a"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (67877-429-01)", "package_ndc": "67877-429-01", "marketing_start_date": "20151101"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (67877-429-05)", "package_ndc": "67877-429-05", "marketing_start_date": "20151101"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (67877-429-10)", "package_ndc": "67877-429-10", "marketing_start_date": "20151101"}, {"sample": false, "description": "100 BLISTER PACK in 1 CARTON (67877-429-38) / 10 TABLET in 1 BLISTER PACK", "package_ndc": "67877-429-38", "marketing_start_date": "20151101"}], "brand_name": "Gabapentin", "product_id": "67877-429_280c139f-c3a2-46e4-b990-ce3808166e86", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "67877-429", "generic_name": "Gabapentin", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "800 mg/1"}], "application_number": "ANDA206402", "marketing_category": "ANDA", "marketing_start_date": "20151101", "listing_expiration_date": "20261231"}